Clinical Trial Update: N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media [Phase 4]

View source ↗

Summary

A Phase 4 trial of N-Acetylcysteine as an adjunct for refractory chronic suppurative otitis media was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media
• Suppurative Otitis Media

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: St. Paul's Hospital, Canada | Conditions: Otitis Media, Otorrhea | Phase 4 | Status: WITHDRAWN